APA

Wei Z., Zou S., Li F., Cheng Z., Li J., Wang J., Wang C., Chen F., Cao J. & Cheng Y. (20140930). HBsAg is an independent prognostic factor in diffuse large B cell lymphoma patients in rituximab era: result from a multicenter retrospective analysis in China. : Medical oncology (Northwood, London, England).

Chicago

Wei Zheng, Zou Shanhua, Li Feng, Cheng Zhixiang, Li Junmin, Wang Jianmin, Wang Chun, Chen Fangyuan, Cao Junning and Cheng Yunfeng. 20140930. HBsAg is an independent prognostic factor in diffuse large B cell lymphoma patients in rituximab era: result from a multicenter retrospective analysis in China. : Medical oncology (Northwood, London, England).

Harvard

Wei Z., Zou S., Li F., Cheng Z., Li J., Wang J., Wang C., Chen F., Cao J. and Cheng Y. (20140930). HBsAg is an independent prognostic factor in diffuse large B cell lymphoma patients in rituximab era: result from a multicenter retrospective analysis in China. : Medical oncology (Northwood, London, England).

MLA

Wei Zheng, Zou Shanhua, Li Feng, Cheng Zhixiang, Li Junmin, Wang Jianmin, Wang Chun, Chen Fangyuan, Cao Junning and Cheng Yunfeng. HBsAg is an independent prognostic factor in diffuse large B cell lymphoma patients in rituximab era: result from a multicenter retrospective analysis in China. : Medical oncology (Northwood, London, England). 20140930.